Thursday, July 26, 2012

Primatene



epinephrine

Dosage Form: inhalant
Primatene®

MIST

Primatene® Mist (CFC) will not be available after December 31, 2011.

Talk to your doctor and/or pharmacist about other asthma medicines.


Drug Facts



Active ingredient (in each inhalation)


Epinephrine 0.22 mg



Purpose


Bronchodilator



Uses


  • for temporary relief of occasional symptoms of mild asthma:
    • wheezing

    • tightness of chest

    • shortness of breath



Warnings



Asthma alert


Because asthma can be life threatening, see a doctor if you


  • are not better in 20 minutes

  • get worse

  • need 12 inhalations in any day

  • use more than 9 inhalations a day for more than 3 days a week

  • have more than 2 asthma attacks in a week

For inhalation only



Do not use


  • unless a doctor said you have asthma

  • if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs taken for depression, psychiatric or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.


Ask a doctor before use if you have


  • ever been hospitalized for asthma

  • heart disease

  • high blood pressure

  • diabetes

  • thyroid disease

  • seizures

  • narrow angle glaucoma

  • a psychiatric or emotional condition

  • trouble urinating due to an enlarged prostate gland


Ask a doctor or pharmacist before use if you are


  • taking prescription drugs for asthma, obesity, weight control, depression, or psychiatric or emotional conditions

  • taking any drug that contains phenylephrine, pseudoephedrine, ephedrine, or caffeine (such as for allergy, cough-cold, or pain)


When using this product


  • Increased blood pressure or heart rate can occur, which could lead to more serious problems such as heart attack and stroke. Your risk may increase if you take more frequently or more than the recommeded dose.

  • nervousness, sleeplessness, rapid heart beat, tremor, and seizure may occur. If these symptoms persist or get worse, consult a doctor right away.

  • avoid caffeine-containing foods or beverages.

  • avoid dietary supplements containing ingredients reported or claimed to have stimulant effect.

  • do not puncture or throw into incinerator. Contents under pressure.

  • do not use or store near open flame or heat above 120°F (49°C). May cause bursting.

Contains CFC 12, 114, substances which harm public health and environment by destroying ozone in the upper atmosphere.



If pregnant or breast-feeding, ask a health professional before use.



Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.



Directions


  • do not exceed dosage

  • supervise children using this product

  • adults and children 4 years and over: start with one inhalation, then wait at least 1minute. If not relieved, use once more. Do not use again for at least 3 hours.

  • children under 4 years of age: ask a doctor


Other information


  • store at room temperature, between 20-25°C (68-77°F)

  • contains no sulfites

  • see insert for mouthpiece use and care instructions


Inactive ingredients


ascorbic acid, dehydrated alcohol (34%), dichlorodifluoromethane (CFC 12), dichlorotetrafluoroethane (CFC 114), hydrochloric acid, nitric acid, purified water



Questions or comments?


call 1-8 Primatene or 1-877-462-8363



DIRECTIONS FOR USE OF MOUTHPIECE


The Primatene Mist mouthpiece, which is enclosed in the Primatene Mist 15 mL size (not the refill size), should be used for inhalation only with Primatene Mist.

















1. Take plastic cap off mouthpiece. (For refills, use mouthpiece from previous purchase.)
2. Take plastic mouthpiece off bottle.
3. Place short end of mouthpiece on bottle.
4. Turn bottle upside down. Place thumb on bottom of mouthpiece over circular button and forefinger on top of vial. Empty the lungs as completely as possible by exhaling.
5. Place mouthpiece in mouth with lips closed around opening. Inhale deeply while squeezing mouthpiece and bottle together. Release immediately and remove unit from mouth, then complete taking the deep breath, drawing medication into your lungs, holding breath as long as comfortable.
6. Exhale slowly keeping lips nearly closed. This helps distribute the medication in the lungs.
7. For storage, place long end of mouthpiece back on bottle and cover with plastic cap.

CARE OF THE MOUTHPIECE


The Primatene Mist mouthpiece should be washed after each use with hot, soapy water, rinsed thoroughly, and dried with a clean, lint-free cloth.


If the unit becomes clogged and fails to spray, please write and send the clogged unit to:

Armstrong Pharmaceuticals, Inc., 423 La Grange Street, West Roxbury, MA 02132



PRINCIPAL DISPLAY PANEL - 15 mL Carton


Primatene®

MIST

Epinephrine Inhalation Aerosol Bronchodilator


For the Temporary Relief of

BRONCHIAL ASTHMA


WITH MOUTHPIECE FOR ORAL INHALATION


Primatene® Mist (CFC) will not be available after December 31, 2011.

Talk to your doctor and/or pharmacist about other asthma medicines.


1/2 FL OZ (15 mL)




PRINCIPAL DISPLAY PANEL - 15 mL Refill Carton


Primatene®

MIST

Epinephrine Inhalation Aerosol Bronchodilator


For the Temporary Relief of

BRONCHIAL ASTHMA


INHALER

REFILL

USE WITH

Primatene

MOUTHPIECE


Primatene® Mist (CFC) will not be available after December 31, 2011.

Talk to your doctor and/or pharmacist about other asthma medicines.


1/2 FL OZ (15 mL)










Primatene MIST 
epinephrine  inhalant










Product Information
Product TypeHUMAN OTC DRUGNDC Product Code (Source)17270-503
Route of AdministrationORALDEA Schedule    








Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Epinephrine (Epinephrine)Epinephrine0.22 mg


















Inactive Ingredients
Ingredient NameStrength
Ascorbic Acid 
alcohol 
dichlorodifluoromethane 
dichlorotetrafluoroethane 
hydrochloric acid 
nitric acid 
water 


















Product Characteristics
Color    Score    
ShapeSize
FlavorImprint Code
Contains      














Packaging
#NDCPackage DescriptionMultilevel Packaging
117270-503-001 INHALER In 1 CARTONcontains a INHALER
1300 SPRAY In 1 INHALERThis package is contained within the CARTON (17270-503-00)










Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA08790705/23/1984







Primatene MIST REFILL 
epinephrine  inhalant










Product Information
Product TypeHUMAN OTC DRUGNDC Product Code (Source)17270-504
Route of AdministrationORALDEA Schedule    








Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Epinephrine (Epinephrine)Epinephrine0.22 mg


















Inactive Ingredients
Ingredient NameStrength
Ascorbic Acid 
alcohol 
dichlorodifluoromethane 
dichlorotetrafluoroethane 
hydrochloric acid 
nitric acid 
water 


















Product Characteristics
Color    Score    
ShapeSize
FlavorImprint Code
Contains      














Packaging
#NDCPackage DescriptionMultilevel Packaging
117270-504-001 INHALER, REFILL In 1 CARTONcontains a INHALER, REFILL
1300 SPRAY In 1 INHALER, REFILLThis package is contained within the CARTON (17270-504-00)










Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA08790705/23/1984


Labeler - Armstrong Pharmaceuticals, Inc. (001185115)









Establishment
NameAddressID/FEIOperations
Armstrong Pharmaceuticals, Inc.001185115MANUFACTURE
Revised: 07/2010Armstrong Pharmaceuticals, Inc.




More Primatene resources


  • Primatene Side Effects (in more detail)
  • Primatene Use in Pregnancy & Breastfeeding
  • Primatene Drug Interactions
  • Primatene Support Group
  • 6 Reviews for Primatene - Add your own review/rating


Compare Primatene with other medications


  • Adams-Stokes Syndrome
  • Allergic Reactions
  • Asthma, acute
  • Asystole
  • AV Heart Block
  • COPD, Acute
  • Electromechanical Dissociation
  • Shock

No comments:

Post a Comment